S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LTRN Lantern Pharma Inc

4.44

-0.25 (-5.33%)

21 Jun 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Lantern Pharma (NASDAQ:LTRN)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Lantern Pharma Charts.

Lantern Pharma (NASDAQ:LTRN)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Lantern Pharma Charts.

Lantern Pharma Inc News

Form 8-K - Current report
Tuesday 18 June 2024 (3 days ago) • Edgar (US Regulatory)

Lantern Pharma Receives Certificate of Patent from Japanese Patent Office (JPO) for Composition of Matter Covering Drug Candidate LP-284
Wednesday 12 June 2024 (1 week ago) • Business Wire

Form EFFECT - Notice of Effectiveness
Tuesday 11 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 25 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 25 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Saturday 25 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Oregon Therapeutics et Lantern Pharma lancent une collaboration stratégique dans le domaine de l’intelligence artificielle pour optimiser le développement du XCE853, premier candidat médicament de sa catégorie, un puissant inhibiteur...
Monday 13 May 2024 (1 month ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (1 month ago) • Edgar (US Regulatory)

Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights
Friday 10 May 2024 (1 month ago) • Business Wire

Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism
Monday 6 May 2024 (2 months ago) • Business Wire

Lantern Pharma to Report First Quarter 2024 Operating & Financial Results on May 9th, 2024 at 4:30 p.m. ET
Thursday 2 May 2024 (2 months ago) • Business Wire

Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Wednesday 24 April 2024 (2 months ago) • Business Wire

More Lantern Pharma Inc News Articles

Austria-25 Cms Frn

ABEVT192 Ex:19,23

ING Groep International ...

Macquarie Gp 28

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions